181 related articles for article (PubMed ID: 30397488)
1. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.
Yamazoe M; Tomioka H
BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
[TBL] [Abstract][Full Text] [Related]
3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the qSOFA in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Yamazaki R; Nishiyama O; Yoshikawa K; Tohda Y; Matsumoto H
Respir Investig; 2023 May; 61(3):339-346. PubMed ID: 36933282
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
8. Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.
Cao MS; Sheng J; Wang TZ; Qiu XH; Wang DM; Wang Y; Xiao YL; Cai HR
Chin Med J (Engl); 2019 Sep; 132(18):2177-2184. PubMed ID: 31490258
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
[No Abstract] [Full Text] [Related]
10. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Hachisu Y; Murata K; Takei K; Tsuchiya T; Tsurumaki H; Koga Y; Horie T; Takise A; Hisada T
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31086028
[No Abstract] [Full Text] [Related]
11. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.
Teramachi R; Kondoh Y; Kataoka K; Taniguchi H; Matsuda T; Kimura T; Yokoyama T; Yamano Y; Furukawa T; Sakamoto K; Hashimoto N; Hasegawa Y
Respir Med; 2018 Oct; 143():147-152. PubMed ID: 30261987
[TBL] [Abstract][Full Text] [Related]
12. Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis.
Yoo JW; Kim J; Song JW
Sci Rep; 2022 May; 12(1):8817. PubMed ID: 35614114
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
[TBL] [Abstract][Full Text] [Related]
15. Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis.
Tomos I; Dimakopoulou K; Manali ED; Papiris SA; Karakatsani A
Environ Health; 2021 Aug; 20(1):99. PubMed ID: 34461906
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
17. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis.
Kishaba T; Nei Y; Momose M; Nagano H; Yamashiro S
Eurasian J Med; 2018 Feb; 50(1):6-10. PubMed ID: 29531483
[TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
[TBL] [Abstract][Full Text] [Related]
20. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T
Eurasian J Med; 2017 Oct; 49(3):204-206. PubMed ID: 29123445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
